The systemic adverse effects of endoscopic thoracic sympathectomy are underrecognized: a questionnaire-based study

Endoscopic thoracic sympathectomy (ETS) is an established treatment for focal hyperhidrosis and facial blushing; however, its systemic adverse effects remain underrecognized. Beyond compensatory sweating (CS), the potential multisystemic and neuropsychological sequelae of sympathetic disruption have not been comprehensively characterized. An anonymous, cross-sectional online survey was conducted using the internally validated Chang Gung Sympathetic Function Questionnaire (CG-SFQ). The CG-SFQ demonstrated excellent reliability (Cronbach’s α = 0.90–0.95) and construct validity (KMO = 0.85–0.95; Bartlett’s p < 0.001). Adults (≥ 18 years) who had undergone ETS ≥ 1 year previously and healthy controls were compared across four domains—thermoregulatory/sweating, vascular/cutaneous, psychological/central nervous system, and systemic (cardiorespiratory, gastrointestinal, urogenital, musculoskeletal). Symptoms were rated on a 0–10 numeric scale, and intergroup comparisons were performed for prevalence, severity, and proportion of severe cases (≥ 8). A total of 329 participants (152 ETS, 177 controls) were analyzed. ETS patients exhibited significantly higher prevalence and severity across all domains. More than 80% of patients experienced CS in below-neck regions following ETS, with severe intensity exceeding 40%. Vascular dysregulation, paresthesia, and cutaneous changes were frequent. Neurocognitive and mood disturbances—including fatigue, inattention, and anxiety—were markedly elevated, while cardiorespiratory, gastrointestinal, and urogenital complaints were also significantly more common. These findings indicate a widespread disturbance of sympathetic regulation across central and peripheral pathways. ETS produces widespread systemic sequelae beyond CS, involving multiple organ systems and significantly impacting quality of life. These findings highlight the need for selective surgical strategies, thorough preoperative counseling, and exploration of reconstructive or alternative therapies.

Authors

Institutions

Publication Details

Journal
BMC Plastic and Reconstructive Surgery
Published
2025-11-09
DOI
https://doi.org/10.1186/s44452-025-00007-3
Citations
1
Primary Topic
Sympathectomy and Hyperhidrosis Treatments
Type
article
Field-Weighted Citation Impact
1.16
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The systemic adverse effects of endoscopic thoracic sympathectomy are underrecognized: a questionnaire-based study

Johnny Chuieng‐Yi Lu, Lisa Wen‐Yu Chen, David Chwei‐Chin Chuang, Yin‐Kai Chao et al.
1 citations
BMC Plastic and Reconstructive Surgery
Sympathectomy and Hyperhidrosis Treatments
1.16
article

The systemic adverse effects of endoscopic thoracic sympathectomy are underrecognized: a questionnaire-based study

Johnny Chuieng‐Yi Lu, Lisa Wen‐Yu Chen, David Chwei‐Chin Chuang, Yin‐Kai Chao, Tommy Nai‐Jen Chang, Che‐Hsiung Lee, Jung‐Ju Huang, Cheyenne Wei‐Hsuan Sung
article en
1 citations

Abstract

Endoscopic thoracic sympathectomy (ETS) is an established treatment for focal hyperhidrosis and facial blushing; however, its systemic adverse effects remain underrecognized. Beyond compensatory sweating (CS), the potential multisystemic and neuropsychological sequelae of sympathetic disruption have not been comprehensively characterized. An anonymous, cross-sectional online survey was conducted using the internally validated Chang Gung Sympathetic Function Questionnaire (CG-SFQ). The CG-SFQ demonstrated excellent reliability (Cronbach’s α = 0.90–0.95) and construct validity (KMO = 0.85–0.95; Bartlett’s p < 0.001). Adults (≥ 18 years) who had undergone ETS ≥ 1 year previously and healthy controls were compared across four domains—thermoregulatory/sweating, vascular/cutaneous, psychological/central nervous system, and systemic (cardiorespiratory, gastrointestinal, urogenital, musculoskeletal). Symptoms were rated on a 0–10 numeric scale, and intergroup comparisons were performed for prevalence, severity, and proportion of severe cases (≥ 8). A total of 329 participants (152 ETS, 177 controls) were analyzed. ETS patients exhibited significantly higher prevalence and severity across all domains. More than 80% of patients experienced CS in below-neck regions following ETS, with severe intensity exceeding 40%. Vascular dysregulation, paresthesia, and cutaneous changes were frequent. Neurocognitive and mood disturbances—including fatigue, inattention, and anxiety—were markedly elevated, while cardiorespiratory, gastrointestinal, and urogenital complaints were also significantly more common. These findings indicate a widespread disturbance of sympathetic regulation across central and peripheral pathways. ETS produces widespread systemic sequelae beyond CS, involving multiple organ systems and significantly impacting quality of life. These findings highlight the need for selective surgical strategies, thorough preoperative counseling, and exploration of reconstructive or alternative therapies.

BMC Plastic and Reconstructive SurgeryVol. 1(1)
Chang Gung University (TW), Linkou Chang Gung Memorial Hospital (TW)
Openalex Percentile: Top 16%
Sympathectomy and Hyperhidrosis Treatments
1.16
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.